Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS)

Clinical trial NCT01418001 · TERMINATED

Trial details

NCT number: NCT01418001
Sponsor: Memorial Sloan Kettering Cancer Center
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Sarcoma Leiomyosarcoma Malignant Peripheral Nerve Sheath Tumor Malignant Fibrous Histiocytoma/Undifferentiated Pleomorphic Sarcoma

Start date: 2011-08-01
Primary completion: 2015-11-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.